MX2016001030A - Métodos y composiciones que comprenden desmopresina en combinación con un agonista del receptor beta 3-adrenérgico. - Google Patents
Métodos y composiciones que comprenden desmopresina en combinación con un agonista del receptor beta 3-adrenérgico.Info
- Publication number
- MX2016001030A MX2016001030A MX2016001030A MX2016001030A MX2016001030A MX 2016001030 A MX2016001030 A MX 2016001030A MX 2016001030 A MX2016001030 A MX 2016001030A MX 2016001030 A MX2016001030 A MX 2016001030A MX 2016001030 A MX2016001030 A MX 2016001030A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- desmopressin
- beta
- combination
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 title abstract 2
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 title abstract 2
- 229960004281 desmopressin Drugs 0.000 title abstract 2
- 229940126158 β3 adrenergic receptor agonist Drugs 0.000 title abstract 2
- 206010036018 Pollakiuria Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 206010029446 nocturia Diseases 0.000 abstract 1
- 208000022934 urinary frequency Diseases 0.000 abstract 1
- 230000036318 urination frequency Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361857431P | 2013-07-23 | 2013-07-23 | |
| PCT/US2014/047899 WO2015013454A1 (en) | 2013-07-23 | 2014-07-23 | Methods and compositions comprising desmopressin in combination with a beta-3 adrenergic receptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016001030A true MX2016001030A (es) | 2016-10-07 |
Family
ID=51299056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016001030A MX2016001030A (es) | 2013-07-23 | 2014-07-23 | Métodos y composiciones que comprenden desmopresina en combinación con un agonista del receptor beta 3-adrenérgico. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9814753B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3024474B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2016525548A (cg-RX-API-DMAC7.html) |
| KR (3) | KR20160033220A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105579057A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014293141A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2919198A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3024474T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2910361T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2016001030A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015013454A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0623838D0 (en) * | 2006-11-29 | 2007-01-10 | Malvern Cosmeceutics Ltd | Novel compositions |
| PT4104848T (pt) | 2009-06-18 | 2024-01-04 | Acerus Pharmaceuticals Usa Llc | Administração segura de desmopressina |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| CN105579057A (zh) | 2013-07-23 | 2016-05-11 | 阿勒根公司 | 包含与β-3-肾上腺素能受体激动剂组合的去氨加压素的方法和组合物 |
| JP2016525147A (ja) | 2013-07-23 | 2016-08-22 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | ５−α還元酵素阻害剤と組み合わせたデスモプレシンを含む方法及び組成物 |
| KR20170097045A (ko) | 2014-11-20 | 2017-08-25 | 알레간 인코포레이티드 | 알파-아드레날린성 수용체 길항제와 조합된 데스모프레신을 포함하는 방법 및 조성물 |
| CA2969405A1 (en) | 2014-12-03 | 2016-06-09 | Velicept Therapeutics, Inc. | Compositions and methods of using modified release solabegron for lower urinary tract symptoms |
| US20170348263A1 (en) * | 2016-06-03 | 2017-12-07 | Velicept Therapeutics, Inc. | Compositions and methods of using modified release solabegron for lower urinary tract symptoms |
| KR101877834B1 (ko) * | 2017-04-27 | 2018-07-12 | 주식회사 다산제약 | 미라베그론의 신규한 염 및 이의 제조방법 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH495957A (de) | 1966-09-15 | 1970-09-15 | Ceskoslovenska Akademie Ved | Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids |
| US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
| US4316893A (en) | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
| US4405616A (en) | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
| US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4783450A (en) | 1987-04-13 | 1988-11-08 | Warner-Lambert Company | Use of commercial lecithin as skin penetration enhancer |
| NZ241979A (en) | 1991-03-20 | 1996-01-26 | Merck & Co Inc | Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker |
| US5534496A (en) | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
| ES2249846T3 (es) | 1997-12-02 | 2006-04-01 | Archimedes Development Limited | Composiciones para administracion nasal. |
| US7335186B2 (en) | 1998-03-13 | 2008-02-26 | Alexander George Brian O'Neil | Patient controlled drug delivery device |
| US6558695B2 (en) | 1999-12-16 | 2003-05-06 | Dermatrends, Inc. | Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers |
| ES2717656T3 (es) | 2000-11-30 | 2019-06-24 | Valeritas Inc | Dispositivo con microsonda amovible sustancialmente libre sobre el alojamiento |
| US7244703B2 (en) | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
| GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| US6945952B2 (en) | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
| ATE500827T1 (de) * | 2002-11-07 | 2011-03-15 | Astellas Pharma Inc | Mittel zur behandlung von blasenhyperaktivität mit einem essigsäureanilid-derivat als wirkstoff |
| CA2866501A1 (en) * | 2003-11-10 | 2005-05-26 | Allergan, Inc. | Pharmaceutical compositions including low dosages of desmopressin |
| CA2547990C (en) | 2003-12-08 | 2011-08-02 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for insulin treatment |
| DE102005016981A1 (de) | 2005-04-13 | 2006-10-19 | Bayer Healthcare Ag | Kombination zur Therapie bei benigner Prostatahyperplasie |
| CA2633570A1 (en) | 2005-12-21 | 2007-06-28 | Pfizer Products Inc. | Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor |
| WO2007083640A1 (ja) * | 2006-01-18 | 2007-07-26 | Kyorin Pharmaceutical Co., Ltd. | 頻尿及び尿失禁の予防又は治療剤 |
| CA2988753A1 (en) * | 2007-08-06 | 2009-02-12 | Serenity Pharmaceuticals, Llc | Methods and devices for desmopressin drug delivery |
| CN101648017A (zh) | 2008-08-12 | 2010-02-17 | 许洁 | 用于治疗泌尿生殖系统及下尿路疾病的联合药物组合物 |
| US20110144055A1 (en) | 2008-09-04 | 2011-06-16 | Rozmanith Anthony I | Health Care |
| BRPI0923557A2 (pt) | 2008-12-22 | 2016-01-26 | Allergan Inc | administração de desmopressina intranasal |
| WO2010075327A1 (en) | 2008-12-22 | 2010-07-01 | Serenity Pharmaceuticals Corporation | Desmopressin composition |
| PT4104848T (pt) * | 2009-06-18 | 2024-01-04 | Acerus Pharmaceuticals Usa Llc | Administração segura de desmopressina |
| KR20120093859A (ko) * | 2009-10-07 | 2012-08-23 | 머크 샤프 앤드 돔 코포레이션 | 베타 ３ 아드레날린 수용체 효능제 및 항무스카린제를 사용하는 조합 요법 |
| US9119878B2 (en) | 2010-07-08 | 2015-09-01 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US9522129B2 (en) * | 2010-08-03 | 2016-12-20 | Velicept Therapeutics, Inc. | Pharmaceutical Combination |
| WO2012109387A1 (en) | 2011-02-08 | 2012-08-16 | Halozyme, Inc. | Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia |
| MX2014011128A (es) | 2012-03-19 | 2015-08-10 | Wellesley Pharmaceuticals Llc | Formulacion de liberacion prolongada para reducir la frecuencia de miccion y metodo de uso de la misma. |
| TW201422254A (zh) | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
| GB201312155D0 (en) | 2013-07-05 | 2013-08-21 | Ucl Business Plc | Therapeutic invention |
| JP2016525147A (ja) | 2013-07-23 | 2016-08-22 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | ５−α還元酵素阻害剤と組み合わせたデスモプレシンを含む方法及び組成物 |
| CN105579057A (zh) | 2013-07-23 | 2016-05-11 | 阿勒根公司 | 包含与β-3-肾上腺素能受体激动剂组合的去氨加压素的方法和组合物 |
| MX2016002705A (es) | 2013-09-03 | 2016-09-06 | G2B Pharma Inc | Formulacion intranasal para el tratamiento por reanimacion cardiopulmonar (rcp), mantenimiento cardiaco vital (cls), de anafilaxia y/o reacciones anafilactoides. |
| KR20170097045A (ko) | 2014-11-20 | 2017-08-25 | 알레간 인코포레이티드 | 알파-아드레날린성 수용체 길항제와 조합된 데스모프레신을 포함하는 방법 및 조성물 |
-
2014
- 2014-07-23 CN CN201480052301.7A patent/CN105579057A/zh active Pending
- 2014-07-23 CA CA2919198A patent/CA2919198A1/en active Pending
- 2014-07-23 KR KR1020167004515A patent/KR20160033220A/ko not_active Ceased
- 2014-07-23 MX MX2016001030A patent/MX2016001030A/es unknown
- 2014-07-23 EP EP14748451.3A patent/EP3024474B1/en active Active
- 2014-07-23 KR KR1020217025792A patent/KR20210103589A/ko not_active Ceased
- 2014-07-23 DK DK14748451.3T patent/DK3024474T3/da active
- 2014-07-23 JP JP2016529872A patent/JP2016525548A/ja active Pending
- 2014-07-23 AU AU2014293141A patent/AU2014293141A1/en not_active Abandoned
- 2014-07-23 US US14/338,554 patent/US9814753B2/en not_active Expired - Fee Related
- 2014-07-23 WO PCT/US2014/047899 patent/WO2015013454A1/en not_active Ceased
- 2014-07-23 ES ES14748451T patent/ES2910361T3/es active Active
- 2014-07-23 KR KR1020247002750A patent/KR20240015735A/ko not_active Ceased
-
2017
- 2017-11-13 US US15/811,384 patent/US10568927B2/en active Active
-
2020
- 2020-04-01 JP JP2020065913A patent/JP7219736B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20180289769A1 (en) | 2018-10-11 |
| JP2020109122A (ja) | 2020-07-16 |
| KR20240015735A (ko) | 2024-02-05 |
| US20150031613A1 (en) | 2015-01-29 |
| CA2919198A1 (en) | 2015-01-29 |
| AU2014293141A1 (en) | 2016-02-18 |
| US10568927B2 (en) | 2020-02-25 |
| KR20160033220A (ko) | 2016-03-25 |
| JP7219736B2 (ja) | 2023-02-08 |
| JP2016525548A (ja) | 2016-08-25 |
| DK3024474T3 (da) | 2022-03-28 |
| WO2015013454A1 (en) | 2015-01-29 |
| US9814753B2 (en) | 2017-11-14 |
| CN105579057A (zh) | 2016-05-11 |
| EP3024474A1 (en) | 2016-06-01 |
| EP3024474B1 (en) | 2022-01-05 |
| ES2910361T3 (es) | 2022-05-12 |
| KR20210103589A (ko) | 2021-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016001030A (es) | Métodos y composiciones que comprenden desmopresina en combinación con un agonista del receptor beta 3-adrenérgico. | |
| IL267066B (en) | Activin-actrii antagonists and their use for the treatment of bone and other disorders | |
| SG11201705917PA (en) | Low density polishing pad | |
| MX2013015311A (es) | Polipeptidos de enlace de pcsk9 y metodos de uso. | |
| IL240393B (en) | Il-33 antagonists and their uses | |
| GB201521064D0 (en) | Test bench combining high-frequency tribological stress and oligocyclic fatigue | |
| EP2947168A4 (en) | THERMALLY CALIBRATED STEEL MACHINE WIRE HAVING EXCELLENT FATIGUE PROPERTIES, AND SPRING USING THE SAME | |
| ZA201506131B (en) | Kv1.3 antagonists and methods of use | |
| IL256208A (en) | Biomarkers associated with lsd1 inhibitors and their uses | |
| PT3221514T (pt) | Palmilha de travessa | |
| SG10201403725TA (en) | Polishing apparatus, polishing pad positioning method, and polishing pad | |
| PL2997345T3 (pl) | Stanowisko badawcze do badań zmęczeniowych przy obciążeniu niskocyklowym i wysokocyklowym | |
| PL4215137T3 (pl) | Narzędzie kriochirurgiczne | |
| PL3013855T3 (pl) | Zmutowany czynnik viii – kompozycje i sposoby wytwarzania | |
| PL3215676T3 (pl) | Punkt mocujący szyny i płyty podkładowej | |
| SG11201505923QA (en) | Polishing pad | |
| IN2014CN00312A (cg-RX-API-DMAC7.html) | ||
| IL276431A (en) | Treatment of the brain disorders and related symptoms | |
| PL3019242T3 (pl) | Kompozycje i sposoby leczenia zaburzeń neuropsychiatrycznych przy zastosowaniu agonisty receptora endoteliny-B | |
| PL3452659T3 (pl) | Warstwa pośrednia szyny | |
| TWI563074B (en) | Nickel phosphorous cmp compositions and methods | |
| MX2017006655A (es) | Metodos y composiciones que comprenden desmopresina en combinacion con un antagonista del receptor alfa-adrenergico. | |
| MX2016001032A (es) | Metodos y composiciones que comprenden desmopresina en combinacion con un inhibidor de 5-alfa reductasa. | |
| GB201609808D0 (en) | In situ woodwind pad | |
| GB201709497D0 (en) | Tele-dildonics through spherical harmonics |